EVENTS OCCURRING AFTER THE REPORTING PERIODPost 30 June 2019 the company received notice from arcomed ag (arcomed), a supplier for the Infusion business, of its intentionto terminate the distribution agreement with Admedus for the supply of arcomed branded products in Australia and NewZealand. The financial impact of this decision is not known at the time of this report. Apart from this event, there has not arisenin the interval between the end of the financial period and the date of this report any item,transaction or event of a materialand unusual nature likely, in the opinion of the Directors of the Company, to affect significantly the operations of the group, theresults of those operations, or the state of affairs of the Group, in future financial years.
Does this imply there are no talks or deals even in the wings? No qualification to say "but we are in discussion with external parties..." or "orking on a recapitalisation..."
Sentiment; Very concerned
Position: Stranded
- Forums
- ASX - By Stock
- AVR
- Ann: Appendix 4D and Half Yearly Financial Report
Ann: Appendix 4D and Half Yearly Financial Report, page-6
-
- There are more pages in this discussion • 237 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.68 |
Change
0.680(4.53%) |
Mkt cap ! $331.4M |
Open | High | Low | Value | Volume |
$14.90 | $15.75 | $14.85 | $431.9K | 28.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 200 | $15.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.95 | 300 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200 | 15.210 |
1 | 100 | 15.020 |
1 | 332 | 15.000 |
1 | 500 | 14.770 |
1 | 1000 | 14.450 |
Price($) | Vol. | No. |
---|---|---|
15.950 | 300 | 1 |
16.000 | 250 | 1 |
16.030 | 999 | 1 |
16.500 | 971 | 1 |
17.500 | 511 | 2 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |